Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
- Resource Type
- Article
- Authors
- Sperling, Adam S.; Guerra, Veronica A.; Kennedy, James A.; Yan, Yuanqing; Hsu, Joanne I.; Wang, Feng; Nguyen, Andrew T.; Miller, Peter G.; McConkey, Marie E.; Quevedo Barrios, Vanessa A.; Furudate, Ken; Zhang, Linda; Kanagal-Shamanna, Rashmi; Zhang, Jianhua; Little, Latasha; Gumbs, Curtis; Daver, Naval; DiNardo, Courtney D.; Kadia, Tapan; Ravandi, Farhad; Kantarjian, Hagop; Garcia-Manero, Guillermo; Futreal, P. Andrew; Ebert, Benjamin L.; Takahashi, Koichi
- Source
- In Blood 20 October 2022 140(16):1753-1763
- Subject
- Plenary Papers
Clinical Trials and Observations
Hematopoiesis and Stem Cells
Free Research Articles
Myeloid Neoplasia
- Language
- ISSN
- 0006-4971